Look for:

Our offer for

SANTHERA PHARMACEUTICALS HOLDING AG


ISIN:
CH1276028821
WKN:
127602882

2024/07/17 17:30:08
Price
9.76 CHF
Difference 14.29% (1.22)

General attributes

ISINCH1276028821
SymbolSANN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)113 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)9.69 CHF (99)
Ask (Ask size)9.76 CHF (1,999)
Open8.69 CHF
High9.98 CHF
Low8.69 CHF
Close (prev. day)8.54 CHF
VWAP9.447892 CHF
Volume (pcs)88,268
Trading volume833,946.56
Number of trades293
Last size1

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: SANTHERA PHARMACEUTICALS HOLDING AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/07/17 17:30:08
Price
9.76 CHF
Difference 14.29% (1.22)

General attributes

ISINCH1276028821
SymbolSANN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)113 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)9.69 CHF (99)
Ask (Ask size)9.76 CHF (1,999)
Open8.69 CHF
High9.98 CHF
Low8.69 CHF
Close (prev. day)8.54 CHF
VWAP9.447892 CHF
Volume (pcs)88,268
Trading volume833,946.56
Number of trades293
Last size1

Performance and Risk

6m1Y3Y
Perf (%)-3.56%+20.64%-58.56%
Perf (abs.)-0.36+1.67-13.79
Beta0.670.32-0.12
Volatility45.9060.1475.15
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)8.66 CHF (22,057)
Ø price 30 days | Ø volume 30 days (pcs.)9.01 CHF (21,456)
Ø price 100 days | Ø volume 100 days (pcs.)9.48 CHF (23,156)
Ø price 250 days | Ø volume 250 days (pcs.)9.38 CHF (36,868)
YTD High | date11.44 CHF (2024/02/26)
YTD Low | date8.10 CHF (2024/06/25)
52 Weeks High | date14.62 CHF (2023/10/27)
52 Weeks Low | date7.14 CHF (2023/10/11)

All listings for SANTHERA PHARMACEUTICALS HOLDING AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart---0.00-
SIX Swiss Exchange2024/07/1717:309.76 CHF0.83293
London Stock Exchange2021/06/1113:1029.1736 CHF0.001
Frankfurt2019/06/2808:04136.40 EUR0.002
FINRA other OTC Issues2024/02/2218:2311.70 USD0.012
Berlin2019/06/2815:59137.20 EUR0.005

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=11704&ID_TYPE_IMAGE_LOGO=2

Contact Details

SANTHERA PHARMACEUTICALS HOLDING AG
- -
Hohenrainstrasse 24 - 4133 Pratteln
Telefon: +41-61-906-89-50
Fax: +41-61-906-89-51
E-mail: office@santhera.com

PDF Downloads

Company report: SANTHERA PHARMACEUTICALS HOLDING AGPDF Download

Company Profile

Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.

Members of Management Board

Dario EklundChairman of Managing Board
Ana VeraMember of Executive Committee
Andrew SmithMember of Executive Committee
Geert Jan van DaalMember of Executive Committee
Günther MetzMember of Executive Committee
Neville KodkaniMember of Executive Committee
Andreas MissyMember of Executive Committee
Marc SchraderMember of Executive Committee
Oliver StrubMember of Executive Committee
Sabine PilotMember of Executive Committee
Sarah Holmes-KlotzMember of Executive Committee

Board of directors

Otto SchwarzMember of the administrative board
Shabir HashamMember of the administrative board
Bradley MeyerMember of the administrative board
Philipp GutzwillerMember of the administrative board
Thomas MeierChairman of the administrative boar





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer